PC512 MC 25-35

Is this your test? Login to manage it. If not, you can develop a test just like it.

This is a non-interactive preview of the quiz content.

1.
1 point
Saxagliptin is classified as a:
2.
1 point
Saxagliptin
3.
1 point
Which of the following statements regarding Saxagliptin is true?
4.
1 point
of the following do not require dosing changes EXCEPT:
5.
1 point
What type of drug is adalimumab?
6.
1 point
Adalimumab has black box warnings for which of the following?
7.
1 point
Which of the following is not an indication for the use of adalimumab?
8.
1 point
Innate immunity does NOT involve
9.
1 point
Most chemotherapy agents for breast cancer have been known for their side effects such as hair loss and major toxicities in other tissues. Targeted therapies such as ____________ have enabled us minimize chemotherapy toxicities and bind to specific epitopes on breast cancer cells
10.
1 point
Due to the molecular weight and nature of trastuzumab emtansine, the best route for administration for the drug
would be:
11.
1 point
A new breast cancers drug has been approved by the FDA, Okwembamumab ozongamycin (O-Z1). Compared to
trastuzumab emtansine(TDM-1) the following can be predicted about the new drug:
12.
1 point
The decision to use TDM-1 in patients with metastatic breast cancer is based on the fact that:
13.
1 point
When is it contraindicated for a patient to receive rivaroxaban?
I. Mild to moderate renal impairment (CrCl >30 mL/min)
II. Severe renal impairment (CrCl <30 mL/min)
III. Moderate to severe hepatic impairment
14.
1 point
Which of the following is caused by a blood clot?
15.
1 point
Which of the following is a FDA approved indication of rivaroxaban?
I. Treatment of pulmonary embolism (PE)
II. Treatment of deep vein thrombosis (DVT)
III. DVT prophylaxis after hip or knee replacement surgery
IV. Treatment of stroke or systemic embolism
16.
1 point
Which of the following is true?
17.
1 point
What is a potential benefit that tolvaptan has over conivaptan?"
18.
1 point
Why is tolvaptan described as having an “aquaretic effect?”
19.
1 point
Where on the the following pathway does tolvaptan act/bind to produce its "aquaretic effect"?

(A) V2-receptor (GCPR) → (B) cAMP → (C) intracellular vesicles → (D )AQP2 channels on the apical membrane
20.
1 point
Which mechanism of tolvaptan has a longer duration of effect?
21.
1 point
Hyponatremia is more likely in patients with:
22.
1 point
Celecoxib has greater affinity for the COX-2 enzyme versus the COX-1 enzyme because:
23.
1 point
Celecoxib is effective in reducing pain because:
24.
1 point
Celecoxib is used to reduce inflammatory pain. Which of the following is true?
25.
1 point
Celecoxib carries a black box warning for which of the following?
26.
1 point
Which of the following actions of aripiprazole (Abilify) is most likely responsible for observed orthostatic
hypotension?
27.
1 point
Which of the following are black box warnings for use of aripiprazole (Abilify) in the elderly?
28.
1 point
Aripiprazole has activity against which of the following neurotransmitters?
29.
1 point
Which of the following are indications for aripiprazole?
30.
1 point
How does isotretinoin prevent the formation of acne?
31.
1 point
Which of the following is NOT an outcome of RAR/RXR activated transcription
32.
1 point
Isotretinoin is contraindicated in which of the following condition?
33.
1 point
Which of the following statements is true regarding acne?
34.
1 point
Which of the following is TRUE regarding the MOA for Seroquel (Quetiapine)?
35.
1 point
Quetiapine affects the dopamine pathway which involves the area from ventral tegmental area to __________.
36.
1 point
What is the proper administration frequency for Seroquel?
37.
1 point
How is Quetiapine eliminated?
38.
1 point
Which of the following statements about Nexium (Esomeprazole) is false?
39.
1 point
What makes up the triple therapy used to treat H. Pylori?
40.
1 point
Which of the following pathways is inhibited by Esomeprazole?
41.
1 point
Which of the following is NOT an FDA labeled indication for Nexium (esomeprazole)
42.
1 point
Guanfacine has the approved indication(s) for
43.
1 point
What is the correct mechanism of action for guanfacine?
44.
1 point
Which of the following describes the correct clearance pathway of guanfacine?
45.
1 point
Which of the following is not an adverse effect of guanfacine?